These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6388348)

  • 1. Glucose production and utilization in children with glycogen storage disease type I.
    Tsalikian E; Simmons P; Gerich JE; Howard C; Haymond MW
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E513-9. PubMed ID: 6388348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen.
    Rother KI; Schwenk WF
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E774-8. PubMed ID: 7485494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose recycling and production in glycogenosis type I and III: stable isotope technique study.
    Kalderon B; Korman SH; Gutman A; Lapidot A
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E346-53. PubMed ID: 2782400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal rate of enteral glucose administration in children with glycogen storage disease type I.
    Schwenk WF; Haymond MW
    N Engl J Med; 1986 Mar; 314(11):682-5. PubMed ID: 3081806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
    Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
    J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in hyperinsulinemic infants: the effects of fasting and sodium DL-beta-hydroxybutyrate on glucose production and utilization rates.
    Bougnères PF; Ferré P; Chaussain JL; Job JC
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1054-60. PubMed ID: 6352723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose recycling and production in children with glycogen storage disease type I, studied by gas chromatography/mass spectrometry and (U-13C)glucose.
    Kalderon B; Lapidot A; Korman SH; Gutman A
    Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):305-8. PubMed ID: 3242682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketone body turnover during and after exercise in overnight-fasted and starved humans.
    Féry F; Balasse EO
    Am J Physiol; 1983 Oct; 245(4):E318-25. PubMed ID: 6353933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis.
    Chu CA; Wiernsperger N; Muscato N; Knauf M; Neal DW; Cherrington AD
    Metabolism; 2000 Dec; 49(12):1619-26. PubMed ID: 11145127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic responses to exercise after fasting.
    Dohm GL; Beeker RT; Israel RG; Tapscott EB
    J Appl Physiol (1985); 1986 Oct; 61(4):1363-8. PubMed ID: 3536834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose production rates in type 1 glycogen storage disease.
    Collins JE; Bartlett K; Leonard JV; Aynsley-Green A
    J Inherit Metab Dis; 1990; 13(2):195-206. PubMed ID: 2116551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.
    Smit GP; Berger R; Potasnick R; Moses SW; Fernandes J
    Pediatr Res; 1984 Sep; 18(9):879-81. PubMed ID: 6384910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.
    Bougneres PF; Artavia-Loria E; Ferre P; Chaussain JL; Job JC
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1152-7. PubMed ID: 3902870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
    Wise S; Nielsen M; Rizza R
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R; Ninnis R; Keller U
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion.
    Ricanati ES; Tserng KY; Kalhan SC
    Kidney Int Suppl; 1983 Dec; 16():S121-7. PubMed ID: 6376912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.